Revenue: As of FY2025 Q2, the actual value is USD 12.81 M.EPS: As of FY2025 Q2, the actual value is USD -0.04.<h3>Segment Revenue</h3><ul><li>Total Revenue: For the three months ended June 30, 2025, total revenue was $12,806, an increase of 4.2% compared to the same period in 2024. For the six months ended June 30, 2025, total revenue was $25,068, a 2.7% increase compared to the same period in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: For the three months ended June 30, 2025, gross profit was $5,990, a 132.0% increase compared to $2,582 for the same period in 2024. For the six months ended June 30, 2025, gross profit was $12,220, a 28.7% increase compared to $9,493 for the same period in 2024.</li><li>Operating Loss: For the three months ended June 30, 2025, operating loss was - $4,072, compared to - $12,145 for the same period in 2024. For the six months ended June 30, 2025, operating loss was - $9,420, compared to - $20,514 for the same period in 2024.</li><li>Net Loss: For the three months ended June 30, 2025, net loss was - $6,288, compared to - $11,057 for the same period in 2024. For the six months ended June 30, 2025, net loss was - $12,500, compared to - $20,691 for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: For the six months ended June 30, 2025, net cash used in operating activities was - $6,786, compared to - $11,883 for the same period in 2024.</li><li>Net Cash Used in Investing Activities: For the six months ended June 30, 2025, net cash used in investing activities was - $539, compared to - $3,288 for the same period in 2024.</li><li>Net Cash Used in Financing Activities: For the six months ended June 30, 2025, net cash used in financing activities was - $25, compared to - $118 for the same period in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Change in Fair Value of Financial Instruments: For the three months ended June 30, 2025, the change in fair value of financial instruments was - $1,543, compared to $1,140 for the same period in 2024. For the six months ended June 30, 2025, the change in fair value of financial instruments was - $1,669, compared to - $720 for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The Company is focused on reducing negative cash flows from operations in the near to mid-term and expects a reduction in overall selling, general, and administrative expenses in 2025 due to several actions taken in the second half of 2024 and additional reductions projected in the second half of 2025.</li><li>Non-Core Business: The Company is expanding its product line beyond hemp-based products, including botanical-based wellness solutions, and is involved in a collaboration with DeFloria LLC for botanical drug development.</li></ul>

Charlotte's Web Holdings, Inc. | 10-Q: FY2025 Q2 Revenue: USD 12.81 M